Ionic Capital Management’s Cellectar Biosciences, Inc. Series A Warrants CLRBZ Stock Holding History

Ionic Capital Management’s Portfolio CLRBZ Stock Details CLRBZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-145,035	Closed	-$61K	–	416
2016 Q4	$61K	Hold	145,035	–	–	﹤0.01%	330
2016 Q3	$119K	Sell	145,035 -1,588	-1%	-$1.17K	0.01%	343
2016 Q2	$139K	Buy	+146,623	New	+$126K	0.01%	281

Other funds holding CLRBZ

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ionic Capital Management's CLRBZ Position: Q1 2017 in Review

Ionic Capital Management sold out of Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) in Q1 2017, closing a stake of 145,035 shares — an estimated $61K sold.

Ionic Capital Management first reported a position in CLRBZ in Q2 2016 and held it in 3 quarters. The position peaked at $139K in Q2 2016. 2 funds tracked by Wall St. Rank hold CLRBZ as of Q1 2017.

Ionic Capital Management reported no remaining Cellectar Biosciences, Inc. Series A Warrants position as of Q1 2017 after selling out during the quarter.
Ionic Capital Management sold 145,035 Cellectar Biosciences, Inc. Series A Warrants shares in Q1 2017, an estimated $61K.
Ionic Capital Management first reported a position in Cellectar Biosciences, Inc. Series A Warrants in Q2 2016 and held it in 3 quarters.
Ionic Capital Management's Cellectar Biosciences, Inc. Series A Warrants position peaked at $139K in Q2 2016.
2 funds tracked by Wall St. Rank held Cellectar Biosciences, Inc. Series A Warrants as of Q1 2017.

Based on Ionic Capital Management's 13F filing for Q1 2017, filed 15 May 2017.